Tolcapone Treatment of Pathological Gambling
NCT00927563
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Pathological Gambling
Interventions
DRUG:
Tolcapone
Sponsor
University of Chicago